Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
CCRN Stock Forecast 2026-2027
$13.17
Current Price
$408.38M
Market Cap
Buy 0
Hold 9
Sell 0
Wall St Analyst Ratings
Distance to CCRN Price Targets
+0.6%
To High Target of $13.25
+0.6%
To Median Target of $13.25
-24.1%
To Low Target of $10.00
CCRN Price Momentum
-0.1%
1 Week Change
+0.3%
1 Month Change
-1.6%
1 Year Change
+62.6%
Year-to-Date Change
-12.1%
From 52W High of $14.99
+77.3%
From 52W Low of $7.43
📊 TOP ANALYST CALLS
Did CCRN Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Cross Country is one of their latest high-conviction picks.
Latest CCRN Stock Price Targets & Analyst Predictions
Based on our analysis of 2 Wall Street analysts, CCRN has a neutral consensus with a median price target of $13.25 (ranging from $10.00 to $13.25). The overall analyst rating is Buy (6.0/10). Currently trading at $13.17, the median forecast implies a 0.6% upside. This outlook is supported by 0 Buy, 9 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Kevin Steinke at Barrington Research, projecting a 0.6% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
CCRN Analyst Ratings
0
Buy
9
Hold
0
Sell
CCRN Price Target Range
Low
$10.00
Average
$13.25
High
$13.25
Current: $13.17
Latest CCRN Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for CCRN.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jun 8, 2026 | Barrington Research | Kevin Steinke | Market Perform | Maintains | $13.25 |
| May 11, 2026 | Truist Securities | Hold | Maintains | $N/A | |
| May 8, 2026 | Benchmark | Hold | Downgrade | $N/A | |
| May 7, 2026 | Wedbush | Neutral | Downgrade | $N/A | |
| Mar 19, 2026 | Wedbush | Outperform | Upgrade | $N/A | |
| Mar 5, 2026 | Benchmark | Buy | Upgrade | $N/A | |
| Feb 3, 2026 | Wedbush | Neutral | Initiates | $N/A | |
| Dec 9, 2025 | UBS | Neutral | Maintains | $N/A | |
| Jun 17, 2025 | Barrington Research | Market Perform | Maintains | $N/A | |
| May 13, 2025 | UBS | Neutral | Maintains | $N/A | |
| Mar 14, 2025 | Barrington Research | Market Perform | Maintains | $N/A | |
| Feb 6, 2025 | JMP Securities | Market Perform | Reiterates | $N/A | |
| Dec 10, 2024 | Barrington Research | Market Perform | Downgrade | $N/A | |
| Dec 5, 2024 | Truist Securities | Hold | Maintains | $N/A | |
| Nov 7, 2024 | Benchmark | Buy | Maintains | $N/A | |
| Oct 21, 2024 | Truist Securities | Hold | Maintains | $N/A | |
| Aug 8, 2024 | Barrington Research | Outperform | Maintains | $N/A | |
| Aug 1, 2024 | Truist Securities | Hold | Maintains | $N/A | |
| May 6, 2024 | Barrington Research | Outperform | Maintains | $N/A | |
| May 2, 2024 | Benchmark | Buy | Maintains | $N/A |
Cross Country Healthcare Inc. (CCRN) Competitors
The following stocks are similar to Cross Country based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Cross Country Healthcare Inc. (CCRN) Financial Data
Cross Country Healthcare Inc. has a market capitalization of $408.38M with a P/E ratio of 48.3x. The company generates $1.00B in trailing twelve-month revenue with a -9.8% profit margin.
Revenue growth is -17.8% quarter-over-quarter, while maintaining an operating margin of -0.8% and return on equity of -27.0%.
Valuation Metrics
Market Cap
$408.38M
Enterprise Value
$322.28M
P/E Ratio
48.3x
PEG Ratio
0.1x
Price/Sales
0.4x
Growth & Margins
Revenue Growth (YoY)
-17.8%
Gross Margin
+19.7%
Operating Margin
-0.8%
Net Margin
-9.8%
EPS Growth
-17.8%
Financial Health
Cash/Price Ratio
+24.8%
Current Ratio
3.3x
Debt/Equity
0.7x
ROE
-27.0%
ROA
-0.1%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Cross Country Healthcare Inc. (CCRN) Business Model
About Cross Country Healthcare Inc.
What They Do
Provides workforce solutions for healthcare sector.
Business Model
The company generates revenue by offering staffing services including travel nursing, allied health staffing, and permanent placements to healthcare facilities. Additionally, it provides workforce management solutions, ensuring that hospitals maintain optimal staffing levels to enhance patient care.
Additional Information
Cross Country Healthcare is based in Boca Raton, Florida, and addresses critical healthcare staffing shortages across various specialties. Its extensive network and industry expertise position it as a key player in improving healthcare accessibility and operational efficiency in the healthcare sector.
Company Information
Sector
Healthcare
Industry
Medical Care Facilities
Employees
9,605
CEO
Mr. John A. Martins
Country
United States
IPO Year
2001
Website
www.crosscountry.comCross Country Healthcare Inc. (CCRN) Latest News & Analysis
Latest News
Quick Summary
The Schall Law Firm is investigating Cross Country Healthcare, Inc. (NASDAQ: CCRN) for potential securities law violations related to misleading statements to investors.
Why It Matters
The investigation into Cross Country Healthcare for potential securities law violations could lead to legal risks and financial repercussions, impacting its stock performance and investor confidence.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Cross Country Expands AI-Powered Workforce Intelligence for Health Systems Through Exclusive Optimé Solution
1 month ago
Quick Summary
Cross Country Healthcare (Nasdaq: CCRN) has entered a 36-month exclusive partnership to integrate the Optimé workforce solution into its Intellify platform, enhancing workforce optimization and analytics.
Why It Matters
Cross Country Healthcare's partnership enhances its workforce intelligence platform, potentially increasing efficiency and profitability, which may positively impact stock performance and investor sentiment.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Wohl & Fruchter LLP is investigating the proposed sale of Cross Country Healthcare (CCRN) to Knox Lane for $13.25 per share, assessing its fairness.
Why It Matters
The investigation into Cross Country Healthcare's sale price may indicate potential undervaluation, impacting shareholders' perception and future stock performance.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Cross Country Healthcare to be Acquired by Knox Lane in All-Cash Transaction Valued at $437 Million
1 month ago
Quick Summary
Cross Country Healthcare (NASDAQ: CCRN) has agreed to be acquired by Knox Lane for $13.25 per share in cash, as announced in a definitive agreement.
Why It Matters
The acquisition of Cross Country Healthcare at $13.25 per share indicates a premium on its stock, reflecting positive market sentiment and potential growth for investors in healthcare solutions.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Cross Country Healthcare reported Q1 2026 revenue of $241.1 million, an 18% decrease year-over-year. The company posted a net loss of $4.3 million, a 771% increase in losses compared to Q1 2025.
Why It Matters
Cross Country Healthcare's significant revenue decline and worsening net loss highlight operational challenges, potentially impacting stock performance and investor confidence.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Cross Country (CCRN) reported its financial results for Q1 2026, with key metrics available for comparison against Wall Street estimates and previous year figures.
Why It Matters
Cross Country's performance relative to Wall Street estimates and previous year metrics can indicate growth potential or weaknesses, impacting future stock valuations and investor sentiment.
Source: Zacks Investment Research
Market Sentiment:
Neutral
Frequently Asked Questions About CCRN Stock
What is Cross Country Healthcare Inc.'s (CCRN) stock forecast for 2026?
Based on our analysis of 2 Wall Street analysts, Cross Country Healthcare Inc. (CCRN) has a median price target of $13.25. The highest price target is $13.25 and the lowest is $10.00.
Is CCRN stock a good investment in 2026?
According to current analyst ratings, CCRN has 0 Buy ratings, 9 Hold ratings, and 0 Sell ratings. The stock is currently trading at $13.17. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for CCRN stock?
Wall Street analysts predict CCRN stock could reach $13.25 in the next 12 months. This represents a 0.6% increase from the current price of $13.17. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Cross Country Healthcare Inc.'s business model?
The company generates revenue by offering staffing services including travel nursing, allied health staffing, and permanent placements to healthcare facilities. Additionally, it provides workforce management solutions, ensuring that hospitals maintain optimal staffing levels to enhance patient care.
What is the highest forecasted price for CCRN Cross Country Healthcare Inc.?
The highest price target for CCRN is $13.25 from Kevin Steinke at Barrington Research, which represents a 0.6% increase from the current price of $13.17.
What is the lowest forecasted price for CCRN Cross Country Healthcare Inc.?
The lowest price target for CCRN is $10.00 from at , which represents a -24.1% decrease from the current price of $13.17.
What is the overall CCRN consensus from analysts for Cross Country Healthcare Inc.?
The overall analyst consensus for CCRN is neutral. Out of 2 Wall Street analysts, 0 rate it as Buy, 9 as Hold, and 0 as Sell, with a median price target of $13.25.
How accurate are CCRN stock price projections?
Stock price projections, including those for Cross Country Healthcare Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: June 15, 2026 2:28 AM UTC